Human immunodeficiency virus type 1 major neutralizing determinant exposed on hepatitis B surface antigen particles is highly immunogenic in primates.

Por Schlienger, K, Mancini, M, Rivière, Y, Dormont, D, Tiollais, P, Michel, M L
Publicado em 1992

Vaccine-induced neutralizing antibodies directed in part to the simian immunodeficiency virus (SIV) V2 domain were unable to protect rhesus monkeys from SIV experimental challenge.

Por Schlienger, K, Montefiori, D C, Mancini, M, Rivière, Y, Tiollais, P, Michel, M L
Publicado em 1994